Publikationen in Zusammenarbeit mit Forschern von Hospital Universitario Son Espases (7)

2022

  1. A phase II randomised trial of abiraterone acetate plus prednisone in combination with docetaxel or docetaxel plus prednisone after disease progression to abiraterone acetate plus prednisone in patients with metastatic castration-resistant prostate cancer: The ABIDO-SOGUG trial

    European Journal of Cancer, Vol. 175, pp. 110-119

2018

  1. Preliminary safety results of the randomized phase II ABIDO-SOGUG trial: Toxicity profile of concomitant abiraterone acetate + docetaxel treatment in comparison to docetaxel

    Annals of oncology : official journal of the European Society for Medical Oncology, Vol. 29, pp. viii286

2015

  1. Updated recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer

    Critical Reviews in Oncology/Hematology, Vol. 96, Núm. 2, pp. 308-318

2014

  1. SEOM Clinical guidelines for the treatment of metastatic prostate cancer

    Clinical and Translational Oncology, Vol. 16, Núm. 12, pp. 1060-1066

2012

  1. Recommendations from the Spanish Oncology Genitourinary Group for the treatment of patients with metastatic castration-resistant prostate cancer

    Critical Reviews in Oncology/Hematology, Vol. 83, Núm. 3, pp. 341-352

  2. SEOM guidelines for the treatment of bone metastases from solid tumours

    Clinical and Translational Oncology, Vol. 14, Núm. 7, pp. 505-511

2010

  1. Líneas de investigación y nuevas dianas terapéuticas en cáncer de próstata

    Revisiones en Cancer, Vol. 24, Núm. 4, pp. 191-199